**Note: the release below from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, 15-18 April). Please credit the conference if you use this story**
Data on a test that can detect HIV, hepatitis B and hepatitis C from a single drop of blood is being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, (15-18 April).
More than one million people a year are killed by hepatitis B or hepatitis C. 650,000 people die from HIV-related causes annually and 1.5 million acquire HIV.
The World Health Organisation has made the elimination of all three viruses by 2030 one of its global health strategies but new tests are necessary if case numbers are to be reduced.
The most common test for hepatitis B, hepatitis C and HIV involves taking a blood sample from a vein using a needle. While this method works extremely well, there is a potentially large reservoir of the three conditions in places where this method is not suitable.
This could be prisons, drug rehabilitation centres and homeless shelters, where the taking of venous blood samples isn’t always suitable or countries in which the shipping and refrigerated storage of blood samples can be challenging.
Alternatives include dried blood spot tests, in which a single spot of blood is tested for nucleic acid from the three viruses.
Mr Stephen Nilsson-Møller and colleagues at the Department of Clinical Microbiology, Copenhagen University Hospital, Denmark validated (assessed) one such test.
To do the test, the individual’s finger is pricked and a few spots of blood collected on filter paper and allowed to dry.
The Hologic Panther System – testing equipment widely found in public health laboratories – then uses a technique called transcription mediated amplification to analyse one of the blood spots for genetic material from the three viruses.
The analysis is designed to be, and is normally, run on liquid samples of plasma or serum – not the dried samples used here.
Twenty samples with known amounts of HIV, hepatitis B and hepatitis C were analysed via the dried blood spot method (60 in total) and the viruses were detected in all of the samples.
The plasma was also diluted to determine the lower limit of detection. This showed that it was possible to detect the viruses at levels that are much lower than are normally found in untreated patients.
Mr Nilsson-Møller says: “We’ve shown that using existing hospital equipment, it is possible to detect HIV, hepatitis B and hepatitis C from a single drop of blood.
“The dried blood spot test is ideal for places where you don’t want to use a needle for safety reasons or where it is less practical. This includes prisons, drug rehabilitation centres and homeless shelters.
“It is also suitable for developing countries or places where you run the risk of a blood sample being ruined before it is transferred to a laboratory that can analyse it.
“Blood samples need to be analysed within six hours when kept at room temperature, while dried blood spots can last for nine months without refrigeration.”
Mr Stephen Nilsson-Møller, Department of Clinical Microbiology, Copenhagen University Hospital, Denmark T) +45 3040 4362 E) SNIL0044@regionh.dk
Alternative contact: Tony Kirby in the ECCMID Media Centre. T) +44 7834 385827 E) tony@tonykirby.com
Notes to editors:
The authors declare no conflicts of interest.
Hologic provided Aptima assay kits.
This press release is based on abstract 1727 at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) annual meeting. The material has been peer reviewed by the congress selection committee. There is no full paper at this stage.
Article Publication Date
12-Apr-2023
COI Statement
The authors declare no conflicts of interest